SCHEMBL7111405

SCHEMBL7111405

COC(=O)CCCCCCc1nc(Cl)c2c3c(sc2n1)CCCC3.COC(=O)CCCCCCc1nc(NCc2ccc3c(c2)OCO3)c2c3c(sc2n1)CCCC3

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN12 Q05209 1/20 0.46
PTPN22 Q9Y2R2 1/20 0.46
ALDH1A1 P00352 3/20 0.40
MAPT P10636 4/20 0.40
NPSR1 Q6W5P4 4/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
MEN1 O00255 2/20 0.40
HTT P42858 2/20 0.40
KMT2A Q03164 2/20 0.40
CHRM4 P08173 2/20 0.37
ELANE P08246 1/20 0.37
KDM4E B2RXH2 2/20 0.36
LMNA P02545 1/20 0.36
HPGD P15428 1/20 0.36
STAT3 P40763 1/20 0.36
TP53 P04637 1/20 0.36
TSHR P16473 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
HDAC3 O15379 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5249189 0.96 PTPN12 (0.47) PTPN12PTPN22ALDH1A1MAPTNPSR1
SCHEMBL5251378 0.95 PTPN12 (0.48) PTPN12PTPN22ALDH1A1MAPTNPSR1
SCHEMBL7182035 0.94 PTPN12 (0.48) PTPN12PTPN22ALDH1A1MAPTNPSR1
SCHEMBL6708335 0.93 PTPN12 (0.48) PTPN12PTPN22ALDH1A1MAPTNPSR1
SCHEMBL5251584 0.90 PTPN12 (0.49) PTPN12PTPN22ALDH1A1MAPTNPSR1
SCHEMBL5247483 0.87 PTPN12 (0.49) PTPN12PTPN22ALDH1A1MAPTNPSR1
SCHEMBL5254121 0.86 PTPN12 (0.49) PTPN12PTPN22ALDH1A1MAPTNPSR1
SCHEMBL6214251 0.84 ALDH1A1 (0.41) ALDH1A1MAPTSMN1; SMN2MEN1HTT
SCHEMBL5253984 0.84 PTPN12 (0.50) PTPN12PTPN22ALDH1A1MAPTNPSR1
SCHEMBL5251034 0.84 MAPT (0.43) ALDH1A1MAPTNPSR1SMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1355649-A2 PHARMACEUTICAL FORMULATION CONTAINING PYRAZOLO 4,3-D]PYRIMIDINE AND NITRATES OR THIENOPYRIMIDINES AND NITRATES MERCK PATENT GmbH (DE) 2003-10-29 EP disclosed
EP-1347761-A2 PHARMACEUTICAL FORMULATION CONTAINING THIENOPYRIMIDINES AND ANTITHROMBOTICS, CALCIUM ANTAGONISTS, PROSTAGLANDINS OR PROSTAGLANDIN DERIVATIVES MERCK PATENT GmbH (DE) 2003-10-01 EP disclosed
WO-2002060449-A2 PHARMACEUTICAL FORMULATION CONTAINING PYRAZOLO[4,3-D]PYRIMIDINE AND NITRATES OR THIENOPYRIMIDINES AND NITRATES MERCK PATENT GMBH (DE) 2002-08-08 WO disclosed
WO-2002049650-A2 PHARMACEUTICAL FORMULATION CONTAINING THIENOPYRIMIDINES AND ANTITHROMBOTICS, CALCIUM ANTAGONISTS, PROSTAGLANDINS OR PROSTAGLANDIN DERIVATIVES MERCK PATENT GMBH (DE) 2002-06-27 WO disclosed